Tactical Resources Refiles Q3 Financial Statements and MD&A
Go back to Tactical Resources Refiles Q3 Financial Statements and MD&A| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 29.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.11 | 52 Week High | $117.12 | |||
| Open | $29.11 | 52 Week Low | $46.52 | |||
| Day High | $29.11 | P/E | N/A | |||
| Day Low | $29.11 | EPS | $-1.97 | |||
| Volume | 464 | |||||
| (AMEX: USREF) | Delayed: 5.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.90 | 52 Week High | $ | |||
| Open | $5.90 | 52 Week Low | $ | |||
| Day High | $5.90 | P/E | N/A | |||
| Day Low | $5.90 | EPS | $ | |||
| Volume | 62,332 | |||||
